| Target Price | $4.08 |
| Price | $1.15 |
| Potential |
254.78%
register free of charge
|
| Number of Estimates | 3 |
|
3 Analysts have issued a price target Protagenic Therapeutics Inc 2026 .
The average Protagenic Therapeutics Inc target price is $4.08.
This is
254.78%
register free of charge
$4.20
265.22%
register free of charge
$4.04
251.30%
register free of charge
|
|
| A rating was issued by 7 analysts: 6 Analysts recommend Protagenic Therapeutics Inc to buy, 1 to hold and 0 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
|
Analyst Estimates: Analysts believe that the Protagenic Therapeutics Inc stock has an average upside potential 2026 of
254.78%
register free of charge
|
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.


